Troriluzule

troriluzule · Biohaven Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Troriluzule, covering 2025-08-19 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder [Phase 3]